background: Dysfunction of cellular processes in the testes can lead to infertility, tumourigenesis or other testicular disorders. 14-3-3 proteins are known to play pivotal roles in cellular communication, signal transduction, intracellular trafficking, cell-cycle control, transcription and cytoskeletal structure and have been implicated in several diseases including tumourigenesis. Here we investigated the expression of the 14-3-3 beta isoform in healthy testicular tissues of humans, rats and mice as well as in tissues of Sertoli-cell-only (SCO) syndrome, intratubular germ cell neoplasia (IGCN) and classical seminoma.
Introduction
The 14-3-3 proteins were originally identified in the brain (Moore and Perez, 1967; Ichimura et al., 1988) and are involved in regulating tyrosine and tryptophan hydroxylases and in the biosynthesis of neurotransmitters. Subsequent studies highlighted members of the highly conserved 14-3-3 family to be present in nearly all eukaryotic cells (Obsilová et al., 2008) . In mammalians the expression of seven isotypes of the 14-3-3 protein family, namely beta, epsilon, zeta, eta, theta, gamma and sigma, have been reported. 14-3-3 proteins possess the ability to form homodimers and heterodimers and to bind to a wide range of proteins, including phosphatases, kinases and transmembrane receptors (Aitken et al., 1992; Jones et al., 1995; Dougherty and Morrison, 2004) . Corresponding to the molecular anvil hypothesis, 14-3-3 proteins are capable of changing conformation of the interacting partner and thereby modulating its activity (Yaffe, 2002) . These interactions with the target proteins are often mediated through specific phosphoserine/threonine-containing motifs (Brunet et al., 2002; Aitken, 2006) .
The isotypes of the 14-3-3 protein family are involved in numerous cellular processes: cellular communication, signal transduction, intracellular trafficking, cell-cycle control, transcription and cytoskeletal structure. All these functions are crucial for co-ordinated terminal cell differentiation and the maintenance of the physiological function in differentiated cells (Jin et al., 2004; Aitken, 2006) .
To fulfil these cellular functions, the 14-3-3 isoforms exhibit tissuespecific expression, e.g. in human dermal layer, all isoforms are expressed with the exception of the theta isoform (Kilani et al., 2008) .
Testicular function depends on strict cell-cycle control as well as on rearrangements of the cytoskeleton, both requiring a complex signal transduction. Wong et al. (2009) demonstrated that the 14-3-3 theta isoform plays a pivotal role in regulating and maintaining cell adhesion, both important for the non-impaired function of the blood-testis barrier. Over recent years several studies reported 14-3-3 proteins interacting with the protein kinase, Raf-1, resulting in a concise activation of the mitogenactivated protein kinase (MAPK) signalling module. Such an interaction with Raf-1 is also substantiated for the beta isoform of 14-3-3 (Qiu et al., 2000; Takihara et al., 2000) . FSH and testosterone signalling via cAMP response element-binding protein enhancement is mediated through the MAPK pathway in Sertoli cells, resulting in a change of transcription (Walker and Cheng, 2005) . Besides the documented physiological role of 14-3-3 proteins, they are also implicated in the pathogenesis and maintenance of many diseases, including neurological disorders and cancer (Berg et al., 2003; Tzivion et al., 2006; Komiya et al., 2008) . Recent studies describe the expression of 14-3-3 beta to be up-regulated in astrocytomas, lung cancer or Kaposi's sarcoma, thus being involved in tumourigenesis (Qi et al., 2005; Yang et al., 2009; Zeng et al., 2010) . The overexpression of 14-3-3 beta, in turn, may augment the MAPK activity, thus leading to proliferation and oncogenic transformation of cells (Takihara et al., 2000) .
Up to now, the expression of 14-3-3 beta in testicular tissues has not been investigated. As 14-3-3 beta plays such an important role in a wide range of signalling processes and tumourigenesis, we examined its expression profile in healthy testicular tissue of humans, rats and mice. Additionally, the Sertoli-cell-only (SCO) syndrome, intratubular germ cell neoplasia (IGCN) and one of the most common human testicular tumours, namely classical seminoma, were investigated.
Materials and Methods
Samples of human, rat and mouse testicular tissues were used. Testicular biopsy specimens were fixed in formalin and embedded in paraffin by standard techniques. Sections of 3 mm thickness were cut and mounted on microscope slides.
The formalin-fixed, paraffin-embedded human testicular tissues were obtained from the Department of Urology and from the Department of Pathology, Justus-Liebig-University, Giessen, Germany. Informed consent was obtained from all patients to use parts of the tissues for research purposes.
Immunohistochemistry

Immunofluorescence method
The sections were deparaffinized in xylene and rehydrated in graded ethanol. For primary protein labelling, a monoclonal mouse antibody against 14-3-3 beta (1:100, Santa Cruz Biotechnologies, Santa Cruz, CA, USA, Cat.# sc-25276) and a Cy3-coupled anti-vimentin antibody (1:1000, Sigma-Aldrich, St Louis, MO, USA, Cat.# C9080) was used. Simultaneous primary antibody incubation was done overnight at room temperature. After several washing steps, the sections were incubated with the secondary antibody for 1 h at room temperature. After further washing steps, the cover slips were mounted onto glass slides. Omission of the first antibody was used as an internal negative control. 14-3-3 beta was visualized by Alexa Fluor 488 (Invitrogen GmbH, Frankfurt, Germany) .
For identification of cells and nuclei, the sections were haematoxylin (HE) stained after complete documentation of the immunoreaction.
3,3
′ -Diaminobenzidine staining For visualization of the secondary antibody, Cy3, an excitation filter with a spectrum of 530 -560 nm and an emission filter with a spectrum 572.5 -647 nm were used. Alexa Fluor 488 was visualized by an excitation filter with a range 460 -500 nm and an emission filter with a range 512 -542 nm.
Microscope settings were adjusted by using the negative control as baseline value.
Light microscope was used for visualization of DAB and HE-stained samples.
Immunoblotting
Testicular tissue lysates of all three species were separated on a 10% SDS -polyacrylamide gel electrophoresis gel. Transfer on an Immobilon P membrane (Millipore, Billerica, MA, USA) was performed according to Towbin et al. (1979) . The membrane was blocked with 10% fat-free milk powder in phosphate-buffered saline (PBS) and subsequently incubated for 1 h with antibodies diluted in 0.5% fat-free milk powder in PBS. The specific anti-14-3-3 beta antibody was incubated overnight at 48C. Anti-mouse immunoglobulins (Sigma-Aldrich) were applied for 1 h at room temperature and the reaction was visualized with the SigmaFast S-bromo-D-chloro-3-indolyl phosphate/nitro-blue tetrazolium chloride (Sigma-Aldrich) substrate. A prestained molecular weight marker (Bio-Rad, Hercules, CA, USA) was used for calibration.
Duolink proximity ligation assay
Interaction was detected by Duolink proximity ligation assay (PLA) Kit (O-Link; Bioscience, Uppsala, Sweden: PLA Probe anti-rabbit minus; PLA Probe anti-mouse plus; Detection Kit 563). The PLA probe antirabbit minus binds to the vimentin antibody (Santa Cruz Biotechnologies), whereas the PLA probe anti-mouse plus binds to the 14-3-3 beta antibody. If the distance between both proteins is ,40 nm, a signal with DuoLink PLA is generated, thus indicating an interaction of both proteins (Sö derberg et al., 2006) . After pre-incubation with a blocking agent for 1 h, cryo-fixed samples were incubated overnight with the primary antibodies to vimentin (1:500) and 14-3-3 beta (1:100). Duolink PLA probes detecting rabbit or mouse antibodies were diluted in the blocking agent to a concentration of 1:5 and applied to the slides, followed by incubation for 2 h in a pre-heated humidity chamber at 378C. Unbound PLA probes were removed by washing. For hybridization of the two Duolink PLA probes, Duolink Hybridization stock (dilution 1:5) was used. Sections were incubated in a pre-heated humidity chamber for 15 min at 378C. The samples were incubated in the ligation solution consisting of Duolink Ligation stock (1:5) and Duolink Ligase (1:40) for 90 min at 378C. Detection of the amplified probe was done with the Duolink Detection Kit. Duolink Detection stock was diluted at 1:5 and applied for 1 h at 378C. Final washing steps were done in saline-sodium citrate SSC buffer and 70% ethanol.
Co-immunoprecipitation
Lysates of rat testicular tissue were generated under addition of proteinase inhibit cocktail Complete Mini (Roche Diagnostics, Mannheim, Germany) and phosphatase inhibitor cocktail PhosSTOP (Roche Diagnostics). The total protein of the lysates was measured by the Pierce BCA protein assay Kit (Thermo Scientific, Bonn, Germany) analysed by an Eppendorf Master Photometer.
A total of 2374 mg/ml of rat testicular total proteins were used for co-immunoprecipitation (Co-IP) experiments performed with the Pierce Co-IP Kit (Thermo Scientific).
The Co-IP was done according to the manufacturer's protocol. Ten micrograms of the monoclonal 14-3-3 beta antibody (Santa Cruz Biotechnology) were incubated with the delivered resin and covalently coupled. The antibody-coupled resin was incubated with 200 ml of the whole rat testis protein lysates overnight at 48C. The resin was washed and the protein complexes bound to the antibody were eluted. Subsequent western blot analyses were performed as described before. For the immunodetection, the same antibodies were used as for immunohistochemistry. Tubulin was detected by a monoclonal mouse antibody against beta-tubulin (BioGenex, San Ramon, CA, USA, Cat.# MU178-UC).
Human testis RNA
Human testis total RNA was purchased from Clontech Laboratories (Mountain View, CA, USA) which was isolated by a modified guanidinium thiocyanate method. The mRNA extract was obtained from normal human testes pooled from 39 Caucasians ages 14 -64.
First-strand synthesis
First-strand synthesis was performed using Omniscript, according to the manufacturer's protocol (Qiagen, Hilden, Germany).
Reverse-transcriptase polymerase chain reaction
PCR was performed on an iCycler using SYBR Green Supermix (Bio-Rad). Per sample, 2 ml of cDNA was used for amplification of 14-3-3 beta.
Cycling conditions were 958C for 3 min, followed by 40 cycles of 608C for 30 s, 558C for 30 s and 728C for 1 min. The following primers were used (MWG, Ebersberg, Germany): 5 ′ -CATTCGGCTGTGGAT AGAGA-3 ′ as the forward primer and 5 ′ -TTGAGGGTACAGAGT GACAC-3 ′ as the reverse primer. PCR products were visualized by agarose gel electrophoresis. While amplification of a 90 bp beta-actin product served as a positive control, negative controls included samples lacking RT.
Results
This study demonstrates the expression of the 14-3-3 beta isoform in healthy testicular tissues of human, rat and mouse as well as in SCO syndrome, IGCN and classical seminoma.
14-3-3 beta in healthy testes of humans, rats and mice 14-3-3 beta protein expression in human, rat and mouse testicular tissue extracts was probed by immunoblotting experiments detecting a single band with a molecular weight of 28 kDa (Fig. 1A ). 14-3-3 beta mRNA expression was investigated in human samples of testis by RT-PCR experiments. Here, a transcript could be traced in samples of isolated testis mRNA obtained from 39 healthy Caucasians (Fig. 1B) .
Morphological localization studies of 14-3-3 beta protein in human testes were performed by immunocytochemical staining experiments. The immunostaining shows expression of 14-3-3 beta in Sertoli cells, identified by the expression of vimentin and HE staining ( Fig. 2A-D) . Nuclei of Sertoli cells were highly reactive for 14-3-3 beta antigen, whereas the nucleolus displayed no 14-3-3 staining, and the perinuclear region and cytoplasm displayed a faint staining ( Fig. 2A) . Comparable results for expression and subcellular location of 14-3-3 beta were observed in testes of rats and mice. However, in contrast to human testis, the cytoplasm of both species stained more intensively ( Fig. 2E and I) .
Besides positive reacting Sertoli cells, 14-3-3 beta could also be detected in some Leydig cells, here predominantly restricted to the nucleus (Fig. 3, arrow) . Furthermore, 14-3-3 beta protein was detected in the interstitial connective tissue. Fibrocytes and many endothelial cells lining blood vessels stained 14-3-3 beta positive (Fig. 3, arrowhead) . Leydig cells and blood vessels were identified by subsequent HE staining of the samples (Fig. 3B, D and F) .
All cells, taking part in spermatogenesis, displayed no immunostaining for 14-3-3 beta in none of the investigated species, except a small subset of spermatogonia in human testicular tissues (Fig. 2A) .
The overlay of vimentin and 14-3-3 beta staining in Sertoli cells revealed an overlapping localization of both proteins (Fig. 2C, G and K, arrowhead) in the perinuclear region and the cytoplasm, whereas the nucleoplasm displayed only 14-3-3 beta protein. In the interstitial connective tissue, both proteins also revealed overlapping localization (Fig. 2C, G and K) . To corroborate these results and to confirm an interaction of 14-3-3 beta and vimentin, a Duolink PLA was performed with samples of healthy human, rat and mouse testes. As seen in Fig. 4 , Sertoli cells and interstitial tissues displayed hybridized and amplified antibody-linked nucleotide strands revealing the interaction between 14-3-3 beta and vimentin. Co-IP experiments affirmed the interaction Figure 1 Immunoblotting and RT-PCR of 14-3-3 beta in healthy testes. (A) 14-3-3 beta immunoblot of human (hu), rat (rt) and mouse (ms) testis. (B) 14-3-3 beta RT-PCR of human testes tissue lysates (TTLs). RT-PCR was performed using primers specific to 14-3-3 beta as given in 'Materials and Methods' section. Probes lacking reverse transcriptase served as negative controls (neg). Marker (M) and TTL.
14-3-3 beta in the male reproductive system of 14-3-3 beta and vimentin and revealed tubulin as a further binding partner of 14-3-3 beta (Fig. 5 ). Vimentin and tubulin could be co-immunoprecipitated using an antibody against 14-3-3 beta.
14-3-3 beta in SCO syndrome
Immunohistochemical staining of SCO sections revealed 14-3-3 beta protein expression in Sertoli cells. The staining was predominantly restricted to the nucleus, whereas the cytoplasm showed a less intensive staining (Fig. 6F) .
The testicular stroma, including endothelial cells of blood vessels and fibrocytes, particularly express 14-3-3 beta protein ( Fig. 6B and D) . A subset of Leydig cells in sections of SCO displayed a faint immunoreactivity for 14-3-3 beta predominantly restricted to the nucleus, whereas all other Leydig cells are negative for 14-3-3 beta antigen (Fig. 6D ).
14-3-3 beta in IGCN and seminoma
Samples of human IGCN and seminoma were stained for 14-3-3 beta antigen.
As shown in Fig. 7A (arrow), tumour cells of IGCN revealed an intense 14-3-3 beta immunoreactivity. Both nuclei and cytoplasm contained 14-3-3 beta protein, yet nuclei displayed a much higher staining of 14-3-3 beta protein compared with the cytoplasm (Fig. 7A) . A similar expression pattern of 14-3-3 beta was observed for Sertoli cells (Fig. 7A, arrowhead) .
In seminoma, 14-3-3 beta could be traced in malignant transformed tumour cells (Fig. 7C, arrow) . The immunoreaction for 14-3-3 beta was restricted to the nucleus and with less intensity to the cytoplasm (Fig. 7C) . Infiltrating lymphocytes displayed a heterogeneous immunoreaction. In some lymphocytes, 14-3-3 beta was restricted to the nucleus, whereas in a certain lymphocyte subpopulation 14-3-3 beta was exclusively seen in the cytoplasm (Fig. 7C, double  arrow) .
Furthermore, immunostaining of both IGCN and classical seminoma showed 14-3-3 beta to be present in fibrocytes, in endothelial cells and in smooth muscle cells of blood vessels (Fig. 7, asterisk) .
Discussion
We investigated the expression profile of 14-3-3 beta in the male reproductive system. Besides healthy testicular tissues of humans, rats and mice, SCO syndrome, IGCN and classical seminoma were also analysed.
We were able to show 14-3-3 beta expression in the testis of various species. The protein was found in different cell types of healthy testicular tissues, namely Sertoli cells, Leydig cells, endothelial cells of blood vessels and stromal fibrocytes. Similar observations were made for SCO syndrome except for the Leydig cells, which expressed lower levels of 14-3-3 beta. In comparison with the healthy germ cells, malignant transformed germ cells in IGCN and seminoma displayed 14-3-3 beta protein expression.
On the subcellular level, 14-3-3 beta is predominantly expressed in the nucleus of Sertoli cells as well as in the nucleus of several Leydig cells, fibrocytes and endothelial cells. These results hint at a role for 14-3-3 beta in transcriptional activation of testicular cells. Zippo et al. (2009) suggested that 14-3-3 proteins act as adaptor proteins and thereby driving transcriptional elongation through binding to phosphorylated histone 3. Co-localization of 14-3-3 beta and vimentin was observed in the cytoplasm and in the perinuclear region of Sertoli cells of healthy seminiferous epithelium. Duolink PLA and Co-IP corroborated these observations, indicating the interaction of these two proteins in testis. This is in accordance with the data of Satoh et al. (2004) , who described vimentin to be co-immunoprecipitated with 14-3-3 beta in human astrocytes.
Tubulin, another binding partner of the 14-3-3 beta isoform in testes, may act as microtubules in maintaining the shape of Sertoli cells, transporting cell organelles and regulating spermatogenesis (Vogl et al., 2008) . To establish the role of 14-3-3 beta in these processes further investigations are necessary.
14-3-3 beta in reorganization of the Sertoli-cell cytoskeleton Vimentin, known as an intermediate filament, is expressed in Sertoli cells from immature and adult testes (Zamoner et al., 2007) .
Distinct protein kinases, such as protein kinase A (PKA) and protein kinase C (PKC), are able to phosphorylate vimentin (Tzivion et al., 2000) . When phosphorylated, vimentin polymerization is changed resulting in a branched shape that reaches the apical cell pole. Conversely, dephosphorylation of vimentin by protein phosphatases (PPs) disassembles the elongated vimentin followed by redistribution of vimentin to the perinuclear region (Zhu et al., 1997) . 14-3-3 proteins are known to bind phosphovimentin at specific motifs. Moreover, binding of 14-3-3 proteins to phosphorylated proteins such as Raf-1 diminishes the inactivation by dephosphorylation through PP1 and PP2a (Dent et al., 1995) . Taking into account the observed interaction of 14-3-3 beta and vimentin, we suggest that the interaction of 14-3-3 beta and vimentin stabilizes the elongated vimentin filaments by preventing the dephosphorylation of phosphovimentin in the testis. A lack of testosterone in seminiferous tubules results in a collapse of vimentin filaments in Sertoli cells, leading to spermatogenic apoptosis (Show et al., 2003) . Thus, continuous vimentin expression and the stabilization of the branched phosphovimentin by 14-3-3 beta are essential in normal spermatogenesis.
Several hormones, such as testosterone, FSH and thyroidstimulating hormone, modulate Sertoli cell function and spermatogenesis by PKA, PKC and MAPK signalling cascades (Walker and Cheng, 2005; Zamoner et al., 2007) . The seminiferous epithelium exhibits a cyclic change with altered FSH response during spermatogenesis (Toppari et al., 1991) . Corresponding to these cyclic changes, the cellular distribution of vimentin and 14-3-3 beta varies (Zhu et al., 1997) . Stages with lowest FSH response also showed diminished phosphorylation of vimentin, possibly causing reduced binding of 14-3-3 beta. This reduced interaction destabilizes vimentin and leads to the disassembly of the cytoskeleton and spermiation. As SCO syndrome is characterized by a germinal cell aplasia, there is no spermiation and no cyclic change of the seminiferous epithelium. Under these conditions, we observed 14-3-3 beta bound to phosphovimentin, thus stabilizing the branched filament. 14-3-3 beta in the male reproductive system 14-3-3 beta in Sertoli-cell signalling Interestingly, the function of vimentin is not limited to providing cell integrity. Several studies reported an involvement in signal transduction and stress management of cells (Eriksson et al., 2009) . In addition to its involvement in cytoskeleton rearrangement, 14-3-3 beta could also modulate intracellular signalling pathways. Tzivion et al. (2000) reported that binding of 14-3-3 to phosphovimentin results in a displacement of 14-3-3 binding partners such as Raf-1 or leading to a down-regulation of 14-3-3 protein availability and disassembly of the Raf-1/14-3-3 complexes, both reducing Raf-1 activity. In Sertoli cells, Raf-1 takes part in several signalling pathways activated by FSH, testosterone and epidermal growth factor, such as MAPK pathway (Walker and Cheng, 2005; Cheng et al., 2007; Abé et al., 2008) . Presumably, in Sertoli cells 14-3-3 beta is able to coordinate these signalling pathways by the availability or the displacement of the interaction partners. Cellular stress like heat shock or lack of testosterone leads to dephosphorylation of vimentin (Tzivion et al., 2000; Show et al., 2003) . Thus, 14-3-3 beta availability might be increased by its dissociation from vimentin. Subsequently, 14-3-3 beta interacting partners involved in different signalling cascades can be activated resulting in an adequate response to stress signals in Sertoli cells.
14-3-3 beta in diseased tissues
Besides the function of Sertoli cells, Leydig cells play an important role for a non-impaired spermatogenesis. In healthy testes Leydig cells displayed a predominant nuclear localization of 14-3-3 beta. Interestingly, most Leydig cells of SCO syndrome showed no or only little 14-3-3 beta protein expression. Therefore, it is likely that 14-3-3 proteins may be involved in the pathogenesis or maintenance of azoospermia. Further investigations are necessary to clarify the relevance of 14-3-3 proteins in SCO syndrome.
Distinct specific isoforms of the 14-3-3 protein family are of central interest in tumourigenesis. The 14-3-3 protein family encompasses a group of proteins suppressing tumourigenesis and 14-3-3 proteins promoting cell survival, which may result in malignant transformation. Up to now, detailed mechanisms of malignant transformation or tumour resistance mediated through 14-3-3 proteins are not well elucidated (Morrison, 2009 ). The 14-3-3 beta isoform gains importance in tumourigenesis. In astrocytomas, lung cancer and Kaposi's sarcoma 14-3-3 beta expression was described to be up-regulated (Qi et al., 2005; Yang et al., 2009; Zeng et al., 2010) . Our study provides comparable results. Compared with healthy testes, where 14-3-3 beta expression was very low, malignant transformed cells revealed a high expression of 14-3-3 beta, suggesting an oncogenic potential of 14-3-3 beta.
14-3-3 beta was identified as a positive regulator of the replication machinery by their cruciform binding activity (Zannis-Hadjopoulos et al., 2008) . Thus, 14-3-3 beta could also enhance the growth of transformed germ cells in seminoma and IGCN, independent of survival signalling. Furthermore, 14-3-3 proteins were reported to bind to telomerase reverse transcriptase (TERT), which is up-regulated in many tumours. This binding prevents the nuclear export and is necessary for the anti-apoptotic function of TERT (Tzivion et al., 2006) . In ovarian cancer cells, these processes are induced by estrogen via the AKT (protein kinase B) cascade (Kimura et al., 2004) . Upon stimulation with estrogens in development of testicular germ cell tumours, AKT is highly activated. (McIntyre et al., 2008) . Thus, we postulate that 14-3-3 beta binding to TERT may be involved in the development of testicular germ cell tumours.
Conclusion
A recent review by Sun et al. (2009) stressed the importance of the 14-3-3 protein family in sustaining normal spermatogenesis by regulating cell polarity and cell adhesion. In the present study, focused on the 14-3-3 beta isoform, we demonstrate the direct interaction of 14-3-3 beta and vimentin. Here, 14-3-3 beta may act as both stabilizer of elongated phosphovimentin and coordinator of several signalling pathways. In addition, tubulin was recognized as a further interacting partner of 14-3-3 beta in healthy testes. In tissues of IGCN and classical seminoma, we were able to verify the assumed function of 14-3-3 beta as an oncogen. With regard to our results, the previous knowledge of 14-3-3 function in testes can be extended.
